Las Vegas, NV -- (SBWIRE) -- 02/12/2013 -- A.P. Pharma, Inc. (OTC:APPA) share is trading at $0.73. The company has recently touched its highest of $0.85 last week whereas lowest traded value is $0.29.
A.P. Pharma gain in share price is probably due to increase in investor awareness about the preceding regulatory decision on the company’s product APF530 that is deviced for the treatment of nausea and vomiting during the cancer treatment via chemotherapy. Currently there is large need in the market for the drug that has made company’s stock volatile until final marketing decision.
APF530 is in phase III clinical trial and has been designed to apply over a range of therapeutical areas including pain and inflammation control, nausea and vomiting prevention while chemotherapy etc. The medicine would be able to release drug for long duration of time.
A.P. Pharma, Inc is based in Redwood city, California and is operating in development of pharmaceutical products. The company is using Biochronomer polymer as a basic constituent of their drug that has the ability to release drug over a definite period of time. Beside APF530, A.P. Pharma, Inc has submitted application for two other drugs APF112 and APF580 for post surgical pain relief and long lasting analgesia respectively as well for investigation.
To find out what OTCMAGIC projects for A.P. Pharma Inc for both short term and long term please click here: APPA
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in stock picks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)